In 2019, the Global Initiative for Asthma (GINA) recommended landmark changes in asthma management. This international panel of experts no longer recommend treating adults and adolescents with asthma with short-acting bronchodilators alone. Instead, they should receive symptom-driven prescriptions (in mild asthma) or use a daily corticosteroid-containing inhaler, to reduce the risk of severe exacerbation. How do you help patients navigate this important paradigm shift in asthma management? This educational event is sponsored by Astra Zeneca through an unrestricted educational grant.


Speakers: Dorothy Pardalis, BSc.Phm., CRE, CDE


Dorothy Pardalis currently works as a community pharmacist, specializing in patient-focused services such as smoking cessation, disease state management and medication reviews. Dorothy also works as a clinical pharmacist at the Tilbury District Family Health Team where she conducts comprehensive patient consultations including COPD & Asthma, Diabetes, Medication Reviews and Smoking Cessation. She is a Certified Respiratory and Diabetes Educator.


To review the webinar or receive your continuing education credits, register for OPA’s complimentary CCCEP-accredited online course with a pre-recorded webinar presentation from Dr. Anne K. Ellis and Dorothy Pardalis.


  • Visit
  • Scroll down to the bottom of the page
  • Register by clicking “Add to Cart” and follow the process 
  • Access the course (optional: review recording)
  • Complete the final exam to receive 1.25 CEUs upon successful completion